SaleMetabolic & GLP-1
Retatrutide
Next-generation GLP receptor agonist studied for metabolic signaling and nutrient partitioning pathways
RETA-CA-26E-0199.637%
11.76 mg / 10 mg
$60.00$70.00CAD
Certificate of Analysis — 110iu
Chemical Structure
Latest COA
Buy HGH Canada | Somatropin 110 IU Kit
Janoshik
Batch HGH-CA-26G-100
Result2026-08-10
Added2026-08-25
Avg Purity97.945%
Avg Mass3.86 mg / 11.58 IU
- Formula
- C990H1528N262O300S7
- Mol. weight
- 22,125 Da (191 residues)
- Form
- Lyophilized powder
- Tested by
- Janoshik
In StockGrowth Hormone
BatchHGH-CA-26G-100
Human Growth Hormones (HGH) Canada — 110 IU, Janoshik-Tested
Recombinant Growth Hormone
HGH (Somatropin) is a recombinant form of human growth hormone studied in laboratory settings for its role in growth factor signaling and cellular development pathways. Research often focuses on its interaction with IGF-1–related mechanisms, protein synthesis processes, and overall regulation of metabolic and structural tissue systems in controlled models.
$280.00CAD
Kit of 10 vials — $28.00 per vial
1 × Kit of 10 (10 vials)
Mix & Match
1 kit — no vial discount yet.
Add 2 more kits for 5% off.
After that, 10% at 5 kits, 20% at 10 kits.
Sold as a kit — each one you add to the cart is a complete 10-vial kit. Single vials are not sold separately.
Purity VerifiedLab TestedSecure
Research Use Only
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
HGH, also known as recombinant human growth hormone (somatropin), is a synthetic peptide hormone identical in sequence to endogenous human growth hormone. It is produced using recombinant DNA technology for controlled laboratory research.
In scientific literature, HGH is studied in experimental models examining growth hormone receptor interaction, endocrine signaling cascades, and downstream cellular response systems under in vitro and preclinical research conditions.
Purity
Third-party tested for purity, identity, quantity, and dimer content.
110iu
Compound Properties
Molecular FormulaC990H1528N262O300S7
Molecular Weight22,125 Da (191 residues)
Overview
Recombinant human growth hormone is a 191–amino acid peptide evaluated in research focused on growth hormone receptor activation and endocrine pathway signaling. Experimental studies examine receptor-binding dynamics, IGF-associated pathways, and systemic regulatory frameworks within controlled laboratory environments.
Preclinical and clinical research publications have explored its receptor interaction profile and downstream signaling behavior under structured study conditions.
History
Human growth hormone was originally isolated from pituitary tissue before recombinant DNA technology enabled synthetic production of somatropin. Recombinant HGH became central to endocrine research, allowing for controlled investigation of growth hormone receptor systems and downstream regulatory pathways.
Subsequent research expanded into receptor signaling, metabolic regulation models, and systemic endocrine interaction frameworks.
Key Research Areas
Laboratory investigations into recombinant human growth hormone have focused on growth hormone receptor activation models and downstream endocrine signaling pathways. Research frameworks evaluate IGF-related signaling cascades, systemic regulatory interaction, and receptor-mediated response systems under controlled in vitro and preclinical conditions.
1 of the 4 areas below are addressed directly by a paper cited on this page.
Growth hormone receptor activation models
Addressed on this page by Stevenson 1988, Yudaev 1983, Lostroh 1976. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Stevenson, R.W. et al. (1988) — The synthetic human growth hormone fragment (32–38) increases glucose uptake in the conscious dog.
- Yudaev, N.A. et al. (1983) — The effect of synthetic fragment 31–44 of human growth hormone on glucose uptake by isolated adipose tissue.
- Lostroh, A.J. et al. (1976) — Diabetogenic peptide from human growth hormone: partial purification from peptic digest and long-term action in ob/ob mice. Proc Natl Acad Sci U S A 73(7):2920–2922.
IGF-associated signaling pathway research
No paper cited on this page reports on associated. This heading marks where Human Growth Hormones (HGH) is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Endocrine regulatory framework studies
No paper cited on this page reports on endocrine. This heading marks where Human Growth Hormones (HGH) is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
Receptor-mediated cellular response investigations
No paper cited on this page reports on receptor, mediated or cellular. This heading marks where Human Growth Hormones (HGH) is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
The references section of this page cites 3 primary papers published between 1976 and 1988 — a thin record. Every citation is linked to its PubMed or DOI record so it can be read rather than taken on trust, and the summaries above describe what those papers report rather than what the compound is claimed to do.
Human Growth Hormones (HGH) is frequently listed as a peptide by suppliers in this market. It is not one. The structure published on this page is the compound's actual chemistry, and research on it should be read against its own class rather than against peptide literature.
Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for Human Growth Hormones (HGH), set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.
Also called
Human Growth Hormones (HGH) is also referred to as somatropin, growth hormone, GH.
Preclinical only
Human Growth Hormones (HGH) is commonly described online in connection with muscle growth, fat loss and improved recovery. In the research literature the same compound is filed under growth hormone receptor activation models, IGF-associated signaling pathway research and endocrine regulatory framework studies.
The 3 papers cited on this page, published between 1976 and 1988 (1 in animal models) describe laboratory and animal work. None reports a controlled trial in humans. Findings in cell culture or in a rodent model describe what happened in that system; they do not establish that the same occurs in humans, and this compound is not approved for human use.
Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.
Verification for Human Growth Hormones (HGH) is per lot, not per product. The current 110 IU lot HGH-CA-26G-100 returned 97.945% purity, assayed by Janoshik. Those figures are the laboratory's, published in full rather than reduced to a badge.
The lot code printed on the vial matches the code on the certificate for Human Growth Hormones (HGH). Matching the two is what confirms the unit in hand came from the batch that was tested — a certificate not tied to a lot code proves nothing about any particular unit.
Researchers who buy Human Growth Hormones (HGH) in Canada through Eppix Labs receive the lot described by the certificate above: the code printed on the vial label is the code on the certificate, and both are searchable on the batch verification page.
- Lyophilized storage
- −20 °C long-term; stable at room temperature in transit
- After reconstitution
- 2–8 °C
- Light
- Protect from UV and direct light
- Freeze-thaw
- Avoid repeated cycles
- Vehicle
- Solvent selection depends on the compound; consult the published literature
- Format
- Lyophilized powder
Human Growth Hormones (HGH) is supplied as lyophilized powder. It is not a peptide, and solvent behaviour follows from its own chemistry rather than from the aqueous-vehicle conventions that apply to peptide material — the published literature for this compound is the reference for solvent selection, not a general peptide protocol.
Dry storage below freezing and protection from light are the general controls. As with any lyophilized material, the powder frequently sits as a thin film at the base of the vial and is easy to mistake for an empty vial before inspection.
Vials may appear empty on arrival. Lyophilized material collects at the base of the vial and is often not visible until the vial is inspected under direct light.
Included
- 1 × sealed kit of 10 vials (110 IU / 3mL), batch-labelled
- The batch-linked Certificate of Analysis for the exact lot shipped
- Discreet outer packaging with no product names on the exterior
- Canada Post Xpresspost, tracked, typically 1–2 business days from Canadian stock
Not included
- Bacteriostatic water or any other reconstitution vehicle
- Syringes, needles or filters
- Dosing, administration or protocol guidance of any kind
Reconstitution materials are sourced separately. The reconstitution calculator on this site works out concentrations for a given volume, but it is an arithmetic tool for laboratory record-keeping and not a protocol.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 110 IU of recombinant human growth hormone in a 3mL presentation. Independent third-party testing verifies purity, identity, batch specifications, and dimer levels.
The vial contains only the peptide preparation. Any laboratory materials required for experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
Stevenson, R.W. et al.(1988)
The synthetic human growth hormone fragment (32–38) increases glucose uptake in the conscious dog.
PubMedYudaev, N.A. et al.(1983)
The effect of synthetic fragment 31–44 of human growth hormone on glucose uptake by isolated adipose tissue.
PubMedLostroh, A.J. et al.(1976)
Diabetogenic peptide from human growth hormone: partial purification from peptic digest and long-term action in ob/ob mice. Proc Natl Acad Sci U S A 73(7):2920–2922.
PubMedRelated
Researchers also order
Sale
SaleMetabolic & GLP-1
Tirzepatide
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
TIRZ-CA-26G-1099.634%
11.42 mg / 10 mg
$35.00$40.00CAD
Metabolic & GLP-1
Semaglutide
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
10 mgSEMA-CA-26F-1099.504%
11.27 mg / 10 mg
$70.00CAD
Metabolic & GLP-1
Eloralintide (LY3841136)
This product is supplied as eloralintide (LY3841136), a long-acting, selective amylin receptor agonist studied in research on metabolic and body-weight regulation.
10 mgELOR-CA-26G-1099.810%
12.42 mg / 10 mg
$150.00CAD